Pancreatic cancer: iExosomes target the 'undruggable'

Nature Reviews Cancer 17, 452 (2017). doi:10.1038/nrc.2017.54 Author: Conor A. Bradley Kamerkar et al. have engineered exosomes that target KRASG12D (iExosomes) and have demonstrated the specificity and efficacy of iExosomes in targeting oncogenic KRAS in mouse models of pancreatic cancer.

http://dx.doi.org/10.1038/nrc.2017.54

Source: Nature Reviews Cancer - June 30, 2017 Category: Cancer & Oncology Authors: Conor A. Bradley Tags: Research Highlight Source Type: research

More News: Cancer | Cancer & Oncology | Pancreas | Pancreatic Cancer